The computerized musical device called RESPeRATE helps people breathe slowly and lowers their blood pressure, research shows. The RESPeRATE device sells for about $300. Its manufacturer, InterCure Ltd ...
Is there something vaguely disconcerting about a medical device that comes with a "Quick Start" guide? Don't be scared: InterCure's RESPeRATE is fairly harmless as medi-gadgets go, a specialized audio ...
Feeling more stressed than usual? Here comes technology to the rescue! David Gregg of BehindTheBuy.com stopped by The Early Show Wednesday with several hi-tech products designed to help you chill. All ...
NEW YORK--(BUSINESS WIRE)--InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE: INCR), today announced that RESPeRATE ®, the world’s first FDA-cleared, ...
People suffering from hypertension (also known as high blood pressure) are typically advised to switch to a healthier diet, get more exercise and lose weight, plus they are often put on a combination ...
The product: RESPeRATE looks like the subject line of a junk e-mail, but it’s actually the name of a medical device designed to lower blood pressure by slowing down breathing. Sold over the Internet ...
InterCure Ltd., today announced that RESPeRATE—the only medical device cleared by the FDA and CE-approved for the adjunctive treatment of hypertension. InterCure Ltd., a medical device company ...
It might be hard to believe that anything other than a pill could alleviate hypertension for longer than a couple days, yet evidently, there is a way with the development of RESPeRATE, an electronic ...
NEW YORK--(BUSINESS WIRE)--InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE: INCR), today announced that its RESPeRATE ® hypertension treatment device, ...
Lod, Israel.— September 27th, 2011 — InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE: INCR), today announced that European Journal of Heart Failure, a ...
TEL AVIV, Israel, April 26, 2017 /PRNewswire/ -- 2breathe Technologies Ltd. with its wholly owned U.S. subsidiary Resperate Inc. announced, today, the publication of a new peer reviewed original ...
New York, NY—March 9, 2009—InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE: INCR), today announced a new study published in the peer-reviewed Journal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results